Cefprozil News
Aurobindo Pharma gets US FDA nod for Cefprozil
Drug maker Aurobindo Pharma Ltd. said on Friday it received the U.S. Food and Drug Administration approval for Cefprozil oral suspension variants.
FLAVORx Reports Show December Brings Flavor to Commonly Prescribed Antibiotics
Recent pharmacy reports showed that, in December, the most commonly flavored medications were liquid antibiotics.
Ranbaxy Labs gets USFDA approval for Cefprozil
Ranbaxy Laboratories received an approval from the US Food and Drug Administration to manufacture and market Cefprozil Tablets USP, in 250 mg and 500 mg strengths.
Ranbaxy Q2 global sales at Rs 14,464 mn, 7% growth
The Board of Directors of Ranbaxy Laboratories Limited (RLL) at their meeting held today took on record the un-audited results for the quarter ended June 30, 2006.
Ranbaxy Receives Approval to Market Cefprozil Suspension
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Cefprozil...